Clinical Trial Update: Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Lactobacillus reuteri DSM 17938 for preventing nosocomial diarrhea in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Diarrhea | Phase 3 | Status: COMPLETED